A Multicenter, Open-Label Study of an Intravenous Short-Acting β1-Adrenergic Receptor Antagonist Landiolol Hydrochloride for Coronary Computed Tomography Angiography by 16-Slice Multi-Detector Computed Tomography in Japanese Patients with Suspected Ischemic Cardiac Disease

Masaharu Hirano,Akira Yamashina,Kazuhiro Hara,Yuji Ikari,Masahiro Jinzaki,Misako Iino,Takuhiro Yamaguchi,Mitsunobu Tanimoto,Sachio Kuribayashi

A Multicenter, Open-Label Study of an Intravenous Short-Acting β1-Adrenergic Receptor Antagonist Landiolol Hydrochloride for Coronary Computed Tomography Angiography by 16-Slice Multi-Detector Computed Tomography in Japanese Patients with Suspected Ischemic Cardiac Disease

2014

Masaharu Hirano
Akira Yamashina
Kazuhiro Hara
Yuji Ikari
Masahiro Jinzaki
Misako Iino
Takuhiro Yamaguchi
Mitsunobu Tanimoto
Sachio Kuribayashi

Background During coronary computed tomography (CT) angiography (CCTA), β-blockers (β-adrenergic receptor antagonists) have commonly been used to lower heart rate and improve image quality.

Keywords:

Heart rate
Nuclear medicine
Antagonist
Angiography
Pharmacology
Landiolol
Hydrochloride
Computed tomography angiography
Adrenergic beta-Antagonists
Medicine
Adrenergic receptor
Pathology
β1 adrenergic receptor
open label study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations